BOSTON SCIENTIFIC CORPORATION ULTRAFLEX TRACHEOBRONCHIAL; PROSTHESIS, TRACHEAL, EXPANDABLE
|
Back to Search Results |
|
Model Number M00564860 |
Device Problem
Activation Failure (3270)
|
Patient Problem
Hypoxia (1918)
|
Event Date 07/24/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).Although the suspect device has been received, the evaluation has not been completed.Therefore, the cause of the reported malfunction has not been determined.Upon completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental mdr will be filed.
|
|
Event Description
|
It was reported to boston scientific corporation on (b)(6) 2019 that an ultraflex tracheobronchial stent was to be used to treat a malignant stricture in the airway in the right main trachea during an airway constriction and dilation performed on (b)(6) 2019.Reportedly, the patient's anatomy was not tortuous and was not dilated prior to stent placement.According to the complainant, during the procedure, the stent was fully deployed; however, the stent failed to expand.The stent blocked part of the trachea which caused the patient's oxygen concentration to drop to 68-74.The stent was removed with forceps and another ultraflex tracheobronchial stent was implanted to complete the procedure.Reportedly, the patient received the oxygen up-taking continually for the hypoxia.The patient's condition at the conclusion of the procedure was reported to be stable.
|
|
Event Description
|
It was reported to boston scientific corporation on july 25, 2019 that an ultraflex tracheobronchial stent was to be used to treat a malignant stricture in the airway in the right main trachea during an airway constriction and dilation performed on (b)(6) 2019.Reportedly, the patient's anatomy was not tortuous and was not dilated prior to stent placement.According to the complainant, during the procedure, the stent was fully deployed; however, the stent failed to expand.The stent blocked part of the trachea which caused the patient's oxygen concentration to drop to 68-74.The stent was removed with forceps and another ultraflex tracheobronchial stent was implanted to complete the procedure.Reportedly, the patient received the oxygen up-taking continually for the hypoxia.The patient's condition at the conclusion of the procedure was reported to be stable.
|
|
Manufacturer Narrative
|
Problem code 3270 captures the reportable event of stent failed to expand.An ultraflex tracheobronchial covered stent was received for analysis; the delivery system was not returned.Visual examination of the returned device found the stent was deployed and expanded.The stent was measured to be within specification.No other issues with the stent were noted.The reported event of stent failure to expand could not be confirmed as the stent was received deployed and expanded.Based on all available information, the investigation concluded that the most probable cause classification of the reported hypoxia is known inherent risk of device, which indicates that the adverse event is known and documented in the labelling.The investigation concluded that the reported failure to expand was likely due to anatomical or procedural factors such as characteristics of the lesion, handling of the device, the technique used by the user, and normal procedural difficulties encountered during the procedure, which limited the performance of the device.Therefore, the most probable root cause is adverse event related to procedure.A review of the device history record (dhr) was performed and confirmed that this device met all material, assembly, and performance specifications at the time of release for distribution.A labeling review was performed and, from the information available, this device was used per the directions for use (dfu) / product label.Additionally, "oxygen desaturation related to sedation or procedural instrumentation infection" is noted within the dfu as a potential adverse events associated with the use of this device.
|
|
Search Alerts/Recalls
|
|
|